Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-03

Clinical Trial Update: Oxalate Excretion Profile in Patients with a Heterozygous Mutation of the AGXT (alanine-glyoxylate Aminotransferase) Gene [NA]

View source ↗

Summary

A recruiting clinical trial studying oxalate excretion in patients with a heterozygous AGXT gene mutation, related to primary hyperoxaluria type 1.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Hyperoxaluria (Disorder) | NA | Status: RECRUITING